Vivo Capital, LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$2.2T
Holdings
59
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (59 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX Oncology Holdings Inc | 4,220,048 | $363.8B | 16.23% | |
| 2 | ASNDAscendis Pharma A/S | 1,797,745 | $299.8B | 13.38% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 4,534,341 | $163.9B | 7.31% | |
| 4 | TARSTarsus Pharmaceuticals Inc | 3,245,035 | $134.1B | 5.98% | |
| 5 | —New Frontier Health Corp | 14,300,000 | $123.0B | 5.49% | |
| 6 | ALGSAligos Therapeutics Inc | 3,547,030 | $98.1B | 4.38% | |
| 7 | —Genetron Holdings Ltd | 6,339,860 | $88.8B | 3.96% | |
| 8 | AMRSEURAmyris, Inc | 13,161,847 | $81.3B | 3.63% | |
| 9 | LEGNLegend Biotech Corp Sponsored | 2,755,007 | $77.6B | 3.46% | |
| 10 | OLMAOlema Pharmaceuticals Inc | 1,238,575 | $59.6B | 2.66% | |
| 11 | OPHTEURIveric Bio Inc | 5,966,527 | $41.2B | 1.84% | |
| 12 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 1.70% | |
| 13 | PASGPassage Bio Inc | 1,487,038 | $38.0B | 1.70% | |
| 14 | CRNXCrinetics Pharmaceuticals Inc | 2,335,889 | $33.0B | 1.47% | |
| 15 | NKTXNkarta Inc | 512,225 | $31.5B | 1.41% | |
| 16 | KALVKalVista Pharmaceuticals Inc. | 1,618,296 | $30.7B | 1.37% | |
| 17 | —Sierra Oncology, Inc | 1,917,074 | $30.7B | 1.37% | |
| 18 | ARQTArcutis Biotherapeutics Inc | 867,170 | $24.4B | 1.09% | |
| 19 | —Kadmon Holdings Inc | 5,817,459 | $24.1B | 1.08% | |
| 20 | ZLABZai Lab Ltd ADR | 175,000 | $23.7B | 1.06% | |
| 21 | AVDLAvadel Pharmaceuticals PLC | 3,526,093 | $23.6B | 1.05% | |
| 22 | TCE2Celldex Therapeutics Inc | 1,291,875 | $22.6B | 1.01% | |
| 23 | EPIEUREssa Pharma Inc | 1,893,907 | $22.6B | 1.01% | |
| 24 | CLDNEUREiger BioPharmaceuticals Inc | 1,791,257 | $22.0B | 0.98% | |
| 25 | VRNAVerona Pharma PLC ADR | 3,048,507 | $21.3B | 0.95% | |
| 26 | —Zogenix Inc | 1,006,494 | $20.1B | 0.90% | |
| 27 | 290AChinook Therapeutics Inc | 1,206,266 | $19.1B | 0.85% | |
| 28 | NVV1Novavax Inc | 157,487 | $17.6B | 0.78% | |
| 29 | KURAKura Oncology Inc | 525,262 | $17.2B | 0.77% | |
| 30 | LRMRLarimar Therapeutics Inc | 799,662 | $17.1B | 0.76% | |
| 31 | RCKTRocket Pharmaceuticals Inc | 310,584 | $17.0B | 0.76% | |
| 32 | AKROAkero Therapeutics Inc | 633,426 | $16.3B | 0.73% | |
| 33 | IMVTImmunovant Inc | 347,662 | $16.1B | 0.72% | |
| 34 | ARWRArrowhead Pharmaceuticals Inc | 205,091 | $15.7B | 0.70% | |
| 35 | MREOMereo Biopharma Group PLC | 4,220,938 | $15.1B | 0.67% | |
| 36 | CYTKCytokinetics Inc | 700,000 | $14.5B | 0.65% | |
| 37 | —Zymeworks Inc | 286,064 | $13.5B | 0.60% | |
| 38 | —Curis Inc | 1,400,000 | $11.5B | 0.51% | |
| 39 | ACRSAclaris Therapeutics, Inc. | 1,647,214 | $10.7B | 0.48% | |
| 40 | —Calliditas Therapeutics ADR | 311,030 | $10.5B | 0.47% | |
| 41 | PSTXUSDPoseida Therapeutics Inc | 926,447 | $10.2B | 0.45% | |
| 42 | FIXXEURHomology Medicines, Inc. | 853,143 | $9.6B | 0.43% | |
| 43 | MTNBEURMatinas Biopharma Hldgs Inc | 6,451,612 | $8.8B | 0.39% | |
| 44 | CDXSCodexis, Inc | 388,144 | $8.5B | 0.38% | |
| 45 | TXG10X Genomics Inc | 58,977 | $8.4B | 0.37% | |
| 46 | AUPHAurinia Pharmaceuticals Inc. | 500,732 | $6.9B | 0.31% | |
| 47 | DYNDyne Therapeutics Inc | 315,000 | $6.6B | 0.30% | |
| 48 | ORTXUSDOrchard Therapeutics plc | 1,325,736 | $5.7B | 0.26% | |
| 49 | KALAKala Pharmaceuticals, Inc. | 786,883 | $5.3B | 0.24% | |
| 50 | —Constellation Pharmaceutical | 140,298 | $4.0B | 0.18% | |
| 51 | ATRCAtricure Inc | 64,573 | $3.6B | 0.16% | |
| 52 | CBAYUSDCymabay Therapeutics Inc | 585,394 | $3.4B | 0.15% | |
| 53 | OVIDOvid Therapeutics Inc | 1,250,000 | $2.9B | 0.13% | |
| 54 | 1K0IGM Biosciences Inc | 20,000 | $1.8B | 0.08% | |
| 55 | —VYNE Therapeutics Inc | 939,513 | $1.5B | 0.07% | |
| 56 | 1T7Tricida, Inc. | 174,763 | $1.2B | 0.05% | |
| 57 | DTILPrecision Biosciences Inc | 140,255 | $1.2B | 0.05% | |
| 58 | —Metacrine Inc | 146,426 | $1.2B | 0.05% | |
| 59 | RVMDRevolution Medicines Inc | 16,690 | $661.0M | 0.03% |